Thomas Hegendörfer ,
M.Sc in Molecular Medicine
New Ventures Lead
Thomas Hegendörfer is the New Ventures Lead in Germany for Johnson & Johnson Innovation. He is responsible for identifying collaboration opportunities and forging partnerships between the London Innovation Centre and German innovators and entrepreneurs. He acts as a local key contact for potential German partners, including academic institutions, biotech companies, venture capital, governments and non-profit organizations.
Before joining Johnson & Johnson, Thomas was Head of Business Development at Lead Discovery Center GmbH (LDC), a leading translational center in Germany advancing academic drug discovery into application. In this position, he was responsible for closing numerous partnerships and licensing deals with partners from the pharmaceutical industry and biotech companies across major indications. He held this position for 9 years.
Prior to joining the LDC he worked as a Project Manager in Licensing and Patent Management at Max Planck’s technology transfer agency Max Planck Innovation. Thomas was part of the core team at Max Planck that set up a Transitional Drug Discovery Centre, which finally developed into the LDC.
Thomas graduated with an M.Sc in Molecular Medicine from Imperial College, London, and holds a B.Sc. degree in Molecular Biotechnology from the Technical University of Munich